Panacea

AI-Native FDA Regulatory Services

Spring 2026ActiveHealthcareHealthcare ServicesB2BMedical DevicesBiotechHealthcareAISan Francisco, CA, USA

Company

Panacea provides AI-native FDA regulatory services for Biotechs and Medical Device companies. We hire the most experienced FDA consultants in the industry (ex-FDA, decades of experience, hundreds of filings) and pair them with our AI platform to enable the fastest and lowest cost pathway to FDA approval. While other regulatory consultants bill hourly, our pricing model is simple: fixed, outcome-based pricing. Payment is only due when milestones are complete. We support all FDA regulatory pathways including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, BDD, etc.

Note: This is a preliminary assessment based on limited publicly available information. We did not have access to LinkedIn profiles or live product screenshots for this analysis. We will update this entry with a more thorough review soon.

Verdict

High Signal

Market Opportunity

FDA regulatory consulting is a large, entrenched B2B market — the global regulatory affairs outsourcing market is estimated at $10B+ and growing as biotech/medtech pipelines expand. ICP is crystal clear: biotech and medical device companies navigating complex FDA pathways. Outcome-based pricing is a genuine differentiator in a market that traditionally relies on high-cost hourly billing, creating strong monetization alignment.

Medium Signal

Founder Signal

Haris (CEO) has an MD from Imperial College and GTM/partnerships experience at Anterior (Sequoia/NEA-backed), but no engineering background — he's the non-technical co-founder. Yaman (CTO) is stronger: AI Platform Engineer at Anterior, co-founded Baqi (scaled to $3M+ transactions, 20+ enterprise partnerships), and built distributed systems at Bloomberg on regulatory compliance. BS/MS in CS/AI from UIC. Neither founder appears to have direct FDA regulatory domain expertise, which is notable for a company whose core value proposition rests on hiring experienced ex-FDA consultants.

Medium Signal

Competition

The regulatory consulting space is crowded with established firms (PAREXEL, Regulatory Compliance Associates, NAMSA, Charles River) and AI-native startups entering the space. The combination of ex-FDA human experts + AI platform + fixed pricing is a differentiated wedge, but the moat is not yet clear — the consultants themselves could leave or be replicated, and if the AI layer isn't proprietary, incumbents could copy the model. No direct competitor data was surfaced in research.

Medium Signal

Product

The product concept is clear — AI-augmented FDA regulatory consulting with fixed/outcome-based pricing, covering IND, NDA, BLA, 510(k), PMA, etc. However, no named customer logos, revenue metrics, specific filing success stories, or live demo evidence are present. The website and description are substantive but no hard traction numbers are cited.

OverallB Tier

Panacea has a genuinely differentiated go-to-market angle — outcome-based pricing in a billable-hour-dominated industry is a real wedge, and pairing ex-FDA consultants with AI infrastructure is a sensible thesis. Yaman's background at Anterior (directly relevant) and Baqi gives the technical side credibility. The key risk is that neither founder has direct FDA regulatory domain expertise, making them dependent on hired consultants as the core IP — which is a fragile moat. No demonstrated traction or named customers is a meaningful gap at YC application stage, and the value of the AI platform vs. pure staffing arbitrage needs to be proven. Solid concept in a large market, but execution risk is high given the domain dependency.

Active Founders

Haris Javed-Akhtar

Founder & CEO

ex-GTM (Partnerships Lead) @ Anterior - backed by Sequoia, NEA and Microsoft AI's CEO. MD, Imperial College Medical School, Imperial College Business School.

Yaman Ziadeh

Founder & CTO

Founder & CTO at Panacea (YC P26). Previously AI Platform Engineer at Anterior, building AI infrastructure for health insurers with millions of members. Co-founded Baqi, scaling to $3M+ in transactions and 20+ enterprise partnerships. Built large-scale distributed systems at Bloomberg, leading multi-team regulatory compliance projects. BS/MS in CS and AI from UIC.

Panacea

TierB Tier

BatchSpring 2026

Team Size2

StatusActive

LocationSan Francisco, CA, USA

Disagree with this rating? Let us know

$200 GPU creditsClaim yours →